Peptide P110, which specifically blocks the interaction between DRP1 and Fis1, has been shown to significantly alleviate AKI in mouse and porcine RIRI models by reducing DRP1 mitochondrial recruitment and inhibiting the downstream cGAS-STING inflammatory pathway activation (Song et al., 2024). The gene discussed is DNM1L; the disease is acute kidney injury.